Tomoki Todo

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

James M. Markert, Michael D. Medlock, Samuel D. Rabkin et al. · Gene Therapy · 2000 · 971 citations

Neuro-oncology, Cancer-associated Virus, Glioma +8

Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors

Hiroaki Ikushima, Tomoki Todo, Yasushi Ino et al. · Cell stem cell · 2009 · 545 citations

Glioma-initiating Cells, Sry-related Hmg-box Factors, Signaling Pathway +9

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing

Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin et al. · Proceedings of the National Academy of Sciences · 2001 · 452 citations · Full text

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial

Tomoki Todo, Hirotaka Ito, Yasushi Ino et al. · Nature Medicine · 2022 · 448 citations · Full text

Systemic Antitumor Immunity in Experimental Brain Tumor Therapy Using a Multimutated, Replication-Competent Herpes Simplex Virus

Tomoki Todo, Samuel D. Rabkin, Periasamy Sundaresan et al. · Human Gene Therapy · 1999 · 204 citations

Hsv Vector, Immunology, Immunoediting +20